[Federal Register Volume 85, Number 104 (Friday, May 29, 2020)]
[Notices]
[Pages 32395-32396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11496]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2020-0060]


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHACHSPT) Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
and the Health Resources and Services Administration (HRSA), announces 
the following meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment (CHACHSPT). This meeting is 
open to the public, limited only by audio and web conference lines 
available, by accessing the (information below). Time will be available 
for oral public comment. Persons who desire to make an oral statement, 
may request it at the time of the public comments period on July 21, 
2020 at 3:45 p.m., EDT. Written comments received in advance of the 
meeting will be included in the official record of the meeting.

DATES: The meeting will be held on July 21, 2020, 2:00 p.m. to 4:00 
p.m., EDT.
    Written comments must be received on or before July 14, 2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0060 by any of the following methods. CDC does not accept; comments by 
email.
     Federal eRulemaking Portal: https://www.reulations.gov. 
Follow the instructions for submitting comments.
     Mail: Staci Morris, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, MS E-07, Atlanta, Georgia 30329-4027, 
Attn: CHACHSPT Meeting.
    Instructions: All submissions received must include the Agency name 
and Docket number [CDC-2020-0060]. All relevant comments received in

[[Page 32396]]

conformance with the https://www.regulations.gov suitability policy 
will be posted without change to https://www.regulations.gov, including 
any personal information provided. For access to the docket to read 
background documents or comments received, go to https://www.regulations.gov. Written comments received in advance of the 
meeting will be included in the official record of the meeting.
    Meeting information: The teleconference access is 1-877-603-4228, 
and the passcode is 42598858. The web conference access is https://adobeconnect.cdc.gov/chac/.

FOR FURTHER INFORMATION CONTACT: Staci Morris, Public Health Advisor, 
CDC, 1600 Clifton Road NE, Mailstop E0-7, Atlanta, Georgia 30329-4027, 
Telephone (404) 718-7479, Email [email protected].

SUPPLEMENTARY INFORMATION: Purpose: This committee is charged with 
advising the Director, CDC and the Administrator, HRSA, regarding 
activities related to prevention and control of HIV/AIDS, Viral 
Hepatitis and other STDs, the support of health care services to 
persons living with HIV/AIDS, and education of health professionals and 
the public about HIV/AIDS, Viral Hepatitis and other STDs.

Public Participation

    Written Public Comment: The public is welcome to submit written 
comments in advance of the meeting. Comments should be submitted in 
writing by mail according to the instructions provided. The deadline 
for receipt of written public comment is July 14, 2020. All requests 
must contain the name, address, and organizational affiliation of the 
speaker, as well as the topic being addressed. Written comments 
received in advance of the meeting will be included in the official 
record of the meeting. Please note that comments received, including 
attachments and other supporting materials, are part of the public 
record and are subject to public disclosure.
    Matters To Be Considered: The agenda will include updates on recent 
HRSA and CDC activities involving HIV, STD, and viral hepatitis 
prevention and treatment and related COVID-19 response activities, as 
well as discussions on issues related to youth and the President's 
Initiative on ``Ending the HIV Epidemic: A Plan for America.'' Agenda 
items are subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-11496 Filed 5-28-20; 8:45 am]
BILLING CODE 4163-18-P